skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Find out the latest treatment options and prescribing trends of non-small cell lung cancer (NSCLC)
Download your complimentary report extract today!


Learn the primary research methodology, disease definition and diagnosis, patient segmentation, current treatment options and trends of NSCLC.

 

 

Download your complimentary report extract on NSCLC and discover:

 

 

  • How prescribing trends for the second-line EGFR mutation-positive treatment setting vary significantly across the US, Japan, and five major EU markets.
  • The top three regimens used in the second-line treatment of Stage IV non-squamous EGFR mutation-positive NSCLC patients across the US, Japan, and five major EU markets.
  • The top three regimens used in the second-line treatment of Stage III non-squamous ALK rearrangement-positive NSCLC patients across the US, Japan, and five major EU markets. 
NSCLC infographic download

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: